MATTESINI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 3.708
EU - Europa 1.759
AS - Asia 1.546
SA - Sud America 596
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 56
OC - Oceania 32
Totale 7.757
Nazione #
US - Stati Uniti d'America 3.649
RU - Federazione Russa 805
BR - Brasile 455
SG - Singapore 397
IT - Italia 382
CN - Cina 321
VN - Vietnam 292
HK - Hong Kong 229
IE - Irlanda 150
SE - Svezia 132
KR - Corea 109
AR - Argentina 64
FR - Francia 58
PL - Polonia 56
DE - Germania 52
IN - India 52
FI - Finlandia 40
AU - Australia 31
CA - Canada 28
ID - Indonesia 27
EC - Ecuador 26
ES - Italia 24
BD - Bangladesh 20
GB - Regno Unito 20
CI - Costa d'Avorio 19
JO - Giordania 15
UA - Ucraina 15
ZA - Sudafrica 14
PY - Paraguay 13
IQ - Iraq 12
MX - Messico 12
PK - Pakistan 12
JP - Giappone 10
VE - Venezuela 10
CO - Colombia 9
IR - Iran 7
JM - Giamaica 7
PE - Perù 7
CL - Cile 6
EG - Egitto 6
KE - Kenya 6
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
AZ - Azerbaigian 4
EE - Estonia 4
NL - Olanda 4
PH - Filippine 4
TR - Turchia 4
TW - Taiwan 4
BO - Bolivia 3
SA - Arabia Saudita 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AT - Austria 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PR - Porto Rico 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.697
Città #
Santa Clara 898
Ashburn 399
Fairfield 309
Singapore 291
Hong Kong 193
Seattle 148
Dublin 136
San Jose 135
Woodbridge 133
Houston 131
Cambridge 112
Seoul 109
Milan 103
Ho Chi Minh City 98
Wilmington 90
Beijing 82
Buffalo 66
Hanoi 64
Council Bluffs 62
Franklin 58
Medford 57
Warsaw 55
Moscow 54
Lawrence 53
Rome 49
Los Angeles 47
Princeton 45
The Dalles 45
Lauterbourg 42
São Paulo 34
Chandler 33
Clifton 33
Hefei 33
Mumbai 33
Helsinki 29
Ann Arbor 24
Florence 24
Melbourne 23
New York 22
Altamura 20
Abidjan 19
Munich 19
Shanghai 19
Barcelona 18
Bologna 17
Dallas 17
Dong Ket 16
Phoenix 16
Redondo Beach 16
San Diego 15
Haiphong 14
Kent 14
Brasília 13
Guangzhou 13
Chicago 12
Norwalk 11
Falls Church 10
Turin 10
Da Nang 9
Jakarta 9
Miano 9
Baghdad 8
Frankfurt am Main 8
Hillsboro 8
Montreal 8
Naples 8
Adelaide 7
Biên Hòa 7
Buenos Aires 7
Guayaquil 7
Nuremberg 7
Rio de Janeiro 7
Thái Bình 7
Tokyo 7
Campinas 6
Denver 6
Hải Dương 6
Nairobi 6
Orem 6
Quito 6
Shenzhen 6
Tehran 6
Venice 6
Andover 5
Asunción 5
Bari 5
Curitiba 5
Genoa 5
Goiânia 5
Guarulhos 5
Ha Long 5
Johannesburg 5
London 5
Manaus 5
Manchester 5
Paris 5
Porto Alegre 5
Queens 5
Redmond 5
Salvador 5
Totale 4.903
Nome #
Quality control in treating patients with patent foramen ovale: 7-year-experience of the Heart and Brain team of the Careggi University Hospital 286
The DESolve novolimus bioresorbable Scaffold: From bench to bedside 224
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: A European perspective 211
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 202
Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study 195
Absorb vs. DESolve: An optical coherence tomography comparison of acute mechanical performances 190
A Brief History of Coronary Artery Stents 189
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 186
Percutaneous Trans-septal Mitral Valve-in-Ring Implantation Using a Transcatheter Balloon-Expandable Transcatheter Heart Valve With Elective Intra-Procedural Artero-Venous ECMO in a Patient With Severely Reduced Left Ventricular Ejection Fraction 186
Patent foramen ovale closure: how to choose the right device for the right patient 184
Calcium: A predictor of interventional treatment failure across all fields of cardiovascular medicine 184
A simple step-by-step approach for proficient utilization of the EchoNavigator technology for left atrial appendage occlusion 184
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries 182
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: Insights from the GHOST-EU registry 177
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 176
ABSORB biodegradable stents versus second-generation metal stents: A comparison study of 100 complex lesions treated under OCT guidance 173
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry 170
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 169
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry 168
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 166
Bioabsorbable vascular scaffold overexpansion: Insights from in vitro post-expansion experiments 166
Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events? 165
Impact of stent strut design in metallic stents and biodegradable scaffolds 163
Percutaneous Watchman FLX implantation in a patient with previous mitral valve surgery and large-sized left atrial appendage 163
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 158
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 156
Urgent coronary angiography in out-of-hospital cardiac arrest: a retrospective single centre investigation 150
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry 150
TAVR in patients with hip fracture and severe aortic stenosis: how and when? 150
Il trattamento delle occlusioni coronariche croniche: Stato dell'arte 149
An amber signal lights up before the red: Do not dismiss it 148
Will Optical Coherence Tomography Become the Standard Imaging Tool for Percutaneous Coronary Intervention Guidance? 148
Very high-pressure dilatation for undilatable coronary lesions: Indications and results with a new dedicated balloon 143
Riserva frazionale di flusso: una breve guida pratica all'utilizzo per l'interventista e il punto di vista del cardiologo clinico 142
Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience 141
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting 140
[Tips and tricks for using extracorporeal life support devices in the intensive cardiac care unit] 139
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 137
Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents 130
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: Early and midterm outcomes from the European multicentre GHOST-EU registry 128
Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds 122
EuroCTO Club 2018 meeting: "Experts Live" in Toulouse 119
Bioresorbable Scaffold Thrombosis: Why BRS Size Matters 118
The Forgotten Art of Balloon Angioplasty 118
Inducing persistent flow disturbances accelerates atherogenesis and promotes thin cap fibroatheroma development in D374Y-PCSK9 hypercholesterolemic minipigs 116
Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation 115
No-Reflow Complicating Chronic Total Occlusion Coronary Revascularization 96
Stop adding metal layers: Will bioabsorbable scaffolds become the gold standard for late in-stent restenosis and neo-atherosclerosis? 93
Lower interventricular septal thickness from computed tomography predicts the need for pacemaker implantation after TAVR 72
Ischaemic Stroke in Patients with Known Atrial Fibrillation: A Snapshot from a Large University Hospital Experience 20
Totale 7.757
Categoria #
all - tutte 22.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022306 0 0 19 25 11 17 9 25 15 9 57 119
2022/2023491 77 110 40 16 2 89 73 21 41 2 16 4
2023/2024239 11 29 51 21 16 16 7 37 8 15 19 9
2024/20252.294 100 270 138 336 680 426 17 94 60 48 52 73
2025/20262.834 240 442 260 477 287 94 240 141 170 114 75 294
2026/2027441 167 77 197 0 0 0 0 0 0 0 0 0
Totale 7.757